An Interview with Dr. Anne Peters (Continued)
Obesity Therapies and Bariatric Surgery
Joseph: What do you think about prospects for the obesity drugs that have recently been approved, Qsymia (phentermine and topiramate) and Belviq (lorcaserin)?
Dr. Peters: Obesity drugs do not seem to me to have been wildly successful historically. Now fen-phen, for instance, worked like gangbusters, but it also obviously had problems. (diaTribe Editor's Note: fen-phen contained fenfluramine, which was pulled off the market by FDA in 1997 because it caused heart valve problems.) I still need to see the side effects of the drugs coming down the pipeline. A lot of my patients have tried Topamax (topiramate) and phentermine as a combination, but it's not the extended-release form that's in Qsymia. Topamax is a really effective weight-loss drug, but it often makes patients feel foggy or confused when used in high doses. I don't know what the slow-release form does. I think these drugs might help some, but they are not really going to change the face of type 2 diabetes.
I think a true diet pill has to somehow work by way of the hypothalamus — somewhere up in the eating centers of the brain. But the problem is that eating is such a conserved biological process. It is one of the two functions we must maintain to survive as a species. It is such an amazing mechanism, hunger. If I get too hungry, like if I miss a meal, it just agitates me. I can turn that off somewhat, but not fully. It's like, "Well, what's going to happen; am I going to die because I can't eat for a few hours?" Still, there's something about not being able to eat when you want to eat that upsets the whole system. I think there's a disordered sense of that in people who are overweight, and I don't know if it's induced or it's a part of them, but whatever it is, food is part of the issue.
As an investigator, when I look at a trial, I think it's really important to change people's habits. Currently the only real way to change your habits is bariatric surgery. It's a very effective tool. I haven't been very impressed by gastric banding, but Roux-en-Y gastric bypass and the other bypass procedures have struck me as very effective. The problem is that people can out-eat those too, eventually. It's not really that they changed their habits, just that a change was forced upon them, which is interesting because they can revert back to whatever their bad habits were. I end up taking care of a lot of the complications of post-gastric bypass surgery. It's kind of discouraging.
I like the idea of something that fixes type 2 diabetes, but a lot of people don't want to go through bariatric surgery, and we don't know the very-long-term side effects. It worries me to rearrange people's anatomy. On the other hand, it works. I think it takes away a certain amount of the hyperglycemic load over lifetime if you at least have some response for five or 10 years, which is good.
Joseph: Dr. Peters, thank you for taking the time to talk to us today.
Dr. Peters: You're very welcome.
This article is published on dLife thanks to diaTribe (www.diaTribe.us), an independent, advertising-free e-newsletter for everyone eager to learn about the latest advances in diabetes management. diaTribe is your inside track on diabetes research and products — sign up here for your complimentary lifetime subscription!
NOTE: This information is not intended to be a replacement or substitute for consultation with a qualified medical professional or for professional advice related to diabetes or another medical condition. Please contact your physician or medical professional with any questions and concerns about your medical condition.
Turkey Nachos Tomato Bouillon Pepper, Coriander, and Sesame Seed Crusted Salmon Asian Grilled Pork Tenderloin with Pineapple Sweet Potato Cakes & Salad Southport Shrimp Italian Sandwich Creamy Ground Beef Cornmeal Crusted Tilapia (Gluten Free) "French" Dressing
When the Dexcom monitor flashed a warning that it was time to order a new transmitter, I figured I’d at least have a couple of weeks before it went kaput. So we numbed the back of Charlie’s arm for about 40 minutes, slapped the sensor on him and waited two hours for the warm-up period. And waited. And … waited. Unlike the signal spottiness we experienced occasionally when we were using the Medtronic CGM, the Dexcom...